Ballentine Partners’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
Ballentine Partners's HALO Position: Q3 2026 in Review
Ballentine Partners increased its Halozyme (HALO) stake by 21% in Q3 2026, buying an estimated $128K and bringing the position to 7,660 shares worth $846K. The position accounts for 0.01% of the portfolio, ranked #428.
Ballentine Partners first reported a position in HALO in Q2 2023 and has held it in 14 quarters since. 777 funds tracked by Wall St. Rank hold HALO as of Q3 2026.
- Ballentine Partners held 7,660 shares of Halozyme worth $846K as of Q3 2026.
- Ballentine Partners bought 1,329 Halozyme shares in Q3 2026, an estimated $128K.
- Halozyme made up 0.01% of Ballentine Partners's portfolio in Q3 2026, its #428 holding.
- Ballentine Partners first reported a position in Halozyme in Q2 2023 and has held it in 14 quarters since.
- 777 funds tracked by Wall St. Rank held Halozyme as of Q3 2026.
Based on Ballentine Partners's 13F filing for Q3 2026, filed 13 Nov 2026.